LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $264,107 | -50.3% | 242,300 | +4.4% | 0.00% | – |
| Q2 2023 | $531,280 | +34.2% | 232,000 | +42.4% | 0.00% | – |
| Q1 2023 | $395,847 | +13.7% | 162,900 | -10.6% | 0.00% | – |
| Q4 2022 | $348,193 | -16.1% | 182,300 | +5.5% | 0.00% | – |
| Q3 2022 | $415,000 | +58.4% | 172,800 | +22.7% | 0.00% | – |
| Q2 2022 | $262,000 | -10.9% | 140,800 | 0.0% | 0.00% | – |
| Q1 2022 | $294,000 | -41.4% | 140,800 | +10.6% | 0.00% | – |
| Q4 2021 | $502,000 | -18.0% | 127,300 | 0.0% | 0.00% | – |
| Q3 2021 | $612,000 | +4.8% | 127,300 | 0.0% | 0.00% | – |
| Q2 2021 | $584,000 | +222.7% | 127,300 | +37.3% | 0.00% | – |
| Q1 2020 | $181,000 | -50.8% | 92,714 | +4.6% | 0.00% | – |
| Q4 2019 | $368,000 | +37.8% | 88,614 | 0.0% | 0.00% | – |
| Q3 2019 | $267,000 | -52.1% | 88,614 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $557,000 | +33.6% | 88,614 | +18.3% | 0.00% | – |
| Q1 2019 | $417,000 | -16.1% | 74,914 | 0.0% | 0.00% | -100.0% |
| Q4 2018 | $497,000 | -41.8% | 74,914 | -6.4% | 0.00% | 0.0% |
| Q3 2018 | $854,000 | -11.0% | 80,014 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $960,000 | +39.9% | 80,014 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $686,000 | -13.3% | 80,014 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $791,000 | -19.5% | 80,014 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $983,000 | -25.3% | 80,014 | 0.0% | 0.00% | -50.0% |
| Q2 2017 | $1,316,000 | +14.7% | 80,014 | 0.0% | 0.00% | +100.0% |
| Q1 2017 | $1,147,000 | +3.6% | 80,014 | 0.0% | 0.00% | -50.0% |
| Q4 2016 | $1,107,000 | -23.4% | 80,014 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $1,446,000 | +15.5% | 80,014 | -8.3% | 0.00% | 0.0% |
| Q2 2016 | $1,252,000 | +35.6% | 87,214 | +9.5% | 0.00% | 0.0% |
| Q1 2016 | $923,000 | +4.9% | 79,614 | +20.4% | 0.00% | 0.0% |
| Q4 2015 | $880,000 | +23.9% | 66,114 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $710,000 | +52.0% | 66,114 | +14.0% | 0.00% | +100.0% |
| Q2 2015 | $467,000 | – | 58,014 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $14,779,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $243,430,000 | 5.23% |
| BVF INC/IL | 10,963,000 | $37,493,000 | 1.48% |
| Integral Health Asset Management, LLC | 300,000 | $1,026,000 | 0.30% |
| NEA Management Company, LLC | 2,382,286 | $8,147,000 | 0.22% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $122,000 | 0.13% |
| PINNACLE ASSOCIATES LTD | 1,852,382 | $6,335,000 | 0.13% |
| XTX MARKETS LLC | 13,242 | $45,000 | 0.09% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 828,192 | $2,832,000 | 0.06% |
| WINTON GROUP Ltd | 192,890 | $660,000 | 0.05% |